Gene · 7301
Papers2,825
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 2,825
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
Two Sides of The Same Coin: Normal and Tumoral Stem Cells, The Relevance of In Vitro Models and Therapeutic Approaches: The Experience with Zika Virus in Nervous System Development and Glioblastoma Treatment. | Int J Mol Sci | 2023 | 37686355 | PubTator, text mining | PubMed |
| Zika virus targets human trophoblast stem cells and prevents syncytialization in placental trophoblast organoids. | Nat Commun | 2023 | 37684223 | PubTator, text mining | PubMed |
| Tumor Treating Fields Alter the Kinomic Landscape in Glioblastoma Revealing Therapeutic Vulnerabilities. | Cells | 2023 | 37681903 | PubTator, text mining | PubMed |
| Regulation of brain endothelial cell physiology by the TAM receptor tyrosine kinase Mer. | Commun Biol | 2023 | 37673933 | PubTator, text mining | PubMed |
| TAM family kinases as therapeutic targets at the interface of cancer and immunity. | Nat Rev Clin Oncol | 2023 | 37667010 | PubTator, text mining | PubMed |
| Correction: Receptor tyrosine kinases Tyro3, Axl, and Mertk differentially contribute to antibody-induced arthritis. | Cell Commun Signal | 2023 | 37653485 | PubTator, text mining | PubMed |
| Plasma proteins and onset of type 2 diabetes and diabetic complications: Proteome-wide Mendelian randomization and colocalization analyses. | Cell Rep Med | 2023 | 37652020 | PubTator, text mining | PubMed |
| Targeting MerTK decreases efferocytosis and increases anti-tumor immune infiltrate in prostate cancer. | Med Oncol | 2023 | 37644281 | PubTator, text mining | PubMed |
| The AIDS and Cancer Specimen Resource (ACSR): HIV malignancy specimens and data available at no cost. | AIDS Res Ther | 2023 | 37641153 | PubTator, text mining | PubMed |
| Interferome signature dynamics during the anti-dengue immune response: a systems biology characterization. | Front Immunol | 2023 | 37638052 | PubTator, text mining | PubMed |
| Identification of neutralizing epitopes on the D/A domain of the E2 glycoprotein of classical swine fever virus. | Virus Res | 2023 | 37633596 | PubTator, text mining | PubMed |
| A Review: The Potential Involvement of Growth Arrest-Specific 6 and Its Receptors in the Pathogenesis of Lung Damage and in Coronavirus Disease 2019. | Microorganisms | 2023 | 37630598 | PubTator, text mining | PubMed |
| The Role of microRNAs in Epigenetic Regulation of Signaling Pathways in Neurological Pathologies. | Int J Mol Sci | 2023 | 37629078 | PubTator, text mining | PubMed |
| The Impact of Heavy Smoking on Male Infertility and Its Correlation with the Expression Levels of the PTPRN2 and PGAM5 Genes. | Genes (Basel) | 2023 | 37628668 | PubTator, text mining | PubMed |
| Triple‑negative breast cancer cells that survive ionizing radiation exhibit an Axl‑dependent aggressive radioresistant phenotype. | Exp Ther Med | 2023 | 37614420 | PubTator, text mining | PubMed |
| An integrated view of lipid metabolism in ferroptosis revisited via lipidomic analysis. | Exp Mol Med | 2023 | 37612411 | PubTator, text mining | PubMed |
| Taking early preventive interventions to manage the challenging issue of acquired resistance to third-generation EGFR inhibitors. | Chin Med J Pulm Crit Care Med | 2023 | 37609474 | PubTator, text mining | PubMed |
| Effect of tapered versus stable treatment with tumour necrosis factor inhibitors on disease flares in patients with rheumatoid arthritis in remission: a randomised, open label, non-inferiority trial. | Ann Rheum Dis | 2023 | 37607809 | PubTator, text mining | PubMed |
| Anti-Ro52/Anti-nuclear Matrix Protein 2 Positive Clinically Amyopathic Dermatomyositis Presented Only With Interstitial Lung Disease. | Cureus | 2023 | 37602118 | PubTator, text mining | PubMed |
| TAM receptors in phagocytosis: Beyond the mere internalization of particles. | Immunol Rev | 2023 | 37596991 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7301/papers?page=15